Dr. Natalie A. Moryl, MD

Dr. Moryl practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Moryl's NPI, 1326019365, was assigned on January 28, 2006. Dr. Moryl holds New York license 218388.

Dr. Moryl's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Moryl's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Moryl to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moryl practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Moryl's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Moryl is licensed in New York.

Dmand AI lists acute skin infection, chronic anemia, fibromyalgia and chronic pain and insomnia among the conditions Dr. Moryl treats.

CMS data shows 459 Medicare services from Dr. Moryl across 4 procedure codes in 2024, for 196 Medicare patients. Medicare paid $54,359 for them. Every service was in an office.

CMS counts 196 Medicare patients who saw Dr. Moryl in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moryl's median patient age at 70, with 48% women.

In 2024, Dr. Moryl wrote 1,684 Medicare Part D claims for 239 patients. 88% of them were for generic drugs. CMS names the drug for 1,548 of them, across 30 drugs with 11 or more claims each, at $135,888 in total drug cost. In 2023, CMS named 1,165 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Moryl for performance year 2024, reported as part of a group. Dr. Moryl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moryl as offering telehealth.

Dmand AI links 22 papers to Dr. Moryl, published from 2015 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Analgesics, Opioid, Pain Management and Cancer Pain. Dr. Moryl has published most often in J Natl Compr Canc Netw. Dr. Moryl's most frequent co-authors are Yvona L. Griffo, MD, Deborah R. Korenstein, MD and Anuja Kriplani, MD.

Dr. Moryl is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.